{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-076085","form_type":"8-K","ticker":"SEM","cik":"0001320414","company_name":"SELECT MEDICAL HOLDINGS CORP","filed_at":"2026-06-22T11:38:15+00:00","discovered_at":"2026-06-22T11:40:00.214944+00:00","generated_at":"2026-06-22T11:40:16.457093+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Select Medical supplements merger proxy with deal fees, DCF details after stockholder suits","bullets":["Three lawsuits in NY and PA allege proxy omissions; company denies but voluntarily adds disclosures.","Adds $2.9M fee to Ortenzio and $0.2M to Jackson for roles in structuring the transaction.","Board explored separating critical illness recovery hospital segment from late June 2025.","Goldman Sachs DCF valuation range per share: $15.04-$25.33; net debt $1.818B; 17 precedent deal premia added.","Special meeting on merger remains scheduled for June 26, 2026; company urges stockholders to vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-076085","json":"https://secwatch.observer/filing/0001104659-26-076085.json","markdown":"https://secwatch.observer/filing/0001104659-26-076085.md","text":"https://secwatch.observer/filing/0001104659-26-076085.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1320414/000110465926076085/0001104659-26-076085-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1320414/000110465926076085/tm2618429d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T11:40:16.457093+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}